Ingmar Bruns

Chief Medical Officer, Trillium Therapeutics Inc.

Companies

Zentalis Pharmaceuticals, Inc.Chief Medical Officer Nov 13, 2024 to now¹
Trillium Therapeutics Inc.Chief Medical Officer Jan 4, 2021 to Nov 19, 2021²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Zentalis Pharmaceuticals, Inc. ZNTL33,332 shares³$76.3K at $2.29Feb 9, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 9, 2026Sold 335 shares at $2.39 of Zentalis Pharmaceuticals, Inc.³
Feb 6, 2026Sold 2,962 shares at $2.43 of Zentalis Pharmaceuticals, Inc.³
Feb 6, 2025Bought 20,000 shares at $2.28 of Zentalis Pharmaceuticals, Inc.⁴
Feb 3, 2025Granted 16,629 shares of Zentalis Pharmaceuticals, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARZentalis Pharmaceuticals, Inc., Chief Medical Officer
2
SEC EDGARTrillium Therapeutics Inc., Chief Medical Officer
3
SEC EDGARZentalis Pharmaceuticals, Inc. shares after the filing of Feb 9, 2026
4
SEC EDGARForm 4 filed Feb 12, 2025
5
SEC EDGARForm 4 filed Feb 5, 2025